Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1970 1
1974 2
1975 4
1976 3
1977 2
1978 3
1979 4
1980 2
1981 4
1982 2
1983 5
1984 2
1985 3
1986 7
1987 3
1988 5
1989 3
1990 5
1991 5
1992 3
1993 7
1994 8
1995 2
1996 1
1997 6
1998 3
1999 1
2000 11
2001 9
2002 6
2003 12
2004 5
2005 8
2006 8
2007 15
2008 8
2009 8
2010 8
2011 9
2012 5
2013 14
2014 22
2015 25
2016 16
2017 14
2018 19
2019 24
2020 15
2021 18
2022 20
2023 15
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Abnormal B cell count"
Page 1
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
Li P, Brown S, Williams M, White T, Xie W, Cui W, Peker D, Lei L, Kunder CA, Wang HY, Murray SS, Vagher J, Kovacsovics T, Patel JL. Li P, et al. Blood. 2022 Aug 18;140(7):716-755. doi: 10.1182/blood.2021015135. Blood. 2022. PMID: 35671390 Free PMC article.
This superior OS was determined independent of blast count, abnormal karyotypes, and concurrent variants, including TP53 in patients with AML/MDS, regardless of patient's sex, age, or specific germline CV, suggesting that germline DDX41 variants define a distinct cl …
This superior OS was determined independent of blast count, abnormal karyotypes, and concurrent variants, including TP53 in pa …
Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.
Ballow M, Sánchez-Ramón S, Walter JE. Ballow M, et al. Front Immunol. 2022 Jul 18;13:928062. doi: 10.3389/fimmu.2022.928062. eCollection 2022. Front Immunol. 2022. PMID: 35924244 Free PMC article. Review.
The risk of hematological cancer is increased in PID: for example, lymphomas in PID may be driven by infections such as Epstein-Barr virus, and germline mutations associated with PID are enriched among patients with diffuse large B-cell lymphoma. Clues suggesting an …
The risk of hematological cancer is increased in PID: for example, lymphomas in PID may be driven by infections such as Epstein-Barr virus, …
Unexplained macrocytosis.
Younes M, Dagher GA, Dulanto JV, Njeim M, Kuriakose P. Younes M, et al. South Med J. 2013 Feb;106(2):121-5. doi: 10.1097/SMJ.0b013e3182824cdf. South Med J. 2013. PMID: 23380746
OBJECTIVES: Macrocytosis is a relatively common finding in adult patients undergoing blood cell counting. Approximately 10% of patients will have unexplained macrocytosis after laboratory evaluation. ...A total of 11.6% patients developed a primary bone marrow disorder (tw …
OBJECTIVES: Macrocytosis is a relatively common finding in adult patients undergoing blood cell counting. Approximately 10% of patien …
Monoclonal B-cell lymphocytosis.
Rawstron AC. Rawstron AC. Hematology Am Soc Hematol Educ Program. 2009:430-9. doi: 10.1182/asheducation-2009.1.430. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008229 Review.
Routine diagnostic techniques can now detect very low levels of CLL phenotype cells. Monoclonal B-cell lymphocytosis (MBL) is a relatively recent diagnostic category encapsulating individuals with an abnormal B-cell population but not meeting th …
Routine diagnostic techniques can now detect very low levels of CLL phenotype cells. Monoclonal B-cell lymphocytosis (MBL) is …
Immunology Update: Primary Immunodeficiency Diseases.
Starr SP. Starr SP. FP Essent. 2016 Nov;450:35-53. FP Essent. 2016. PMID: 27869441 Review.
They are caused by complement deficiencies, defects in phagocyte function, impaired T-cell function, and/or impaired B-cell function with antibody deficiencies. Most patients with PIDs will present, at varying ages, with frequent infections. ...If results are abn …
They are caused by complement deficiencies, defects in phagocyte function, impaired T-cell function, and/or impaired B-cell fu …
Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.
Moeini Shad T, Yousefi B, Amirifar P, Delavari S, Rae W, Kokhaei P, Abolhassani H, Aghamohammadi A, Yazdani R. Moeini Shad T, et al. J Clin Immunol. 2021 Jan;41(1):76-88. doi: 10.1007/s10875-020-00881-9. Epub 2020 Oct 14. J Clin Immunol. 2021. PMID: 33052516
BACKGROUND: Ataxia-telangiectasia (AT) is a rare genetic condition, caused by biallelic deleterious variants in the ATM gene, and has variable immunological abnormalities. This study aimed to examine immunologic parameters reflecting cell development, activation, prolifera …
BACKGROUND: Ataxia-telangiectasia (AT) is a rare genetic condition, caused by biallelic deleterious variants in the ATM gene, and has variab …
Evaluation of primary immunodeficiency disease in children.
Reust CE. Reust CE. Am Fam Physician. 2013 Jun 1;87(11):773-8. Am Fam Physician. 2013. PMID: 23939499 Free article. Review.
One in 2,000 children younger than 18 years is thought to have a primary immunodeficiency disease. Antibody, combined B-cell and T-cell, phagocytic, and complement disorders are the most common types. ...Abnormal serum immunoglobulin levels suggest a B …
One in 2,000 children younger than 18 years is thought to have a primary immunodeficiency disease. Antibody, combined B-cell a …
Colony-stimulating factors for febrile neutropenia during cancer therapy.
Bennett CL, Djulbegovic B, Norris LB, Armitage JO. Bennett CL, et al. N Engl J Med. 2013 Mar 21;368(12):1131-9. doi: 10.1056/NEJMct1210890. N Engl J Med. 2013. PMID: 23514290 Free PMC article. Review.
A 55-year-old, previously healthy woman received a diagnosis of diffuse large-B-cell lymphoma after the evaluation of an enlarged left axillary lymph node obtained on biopsy. ...Positron-emission tomography and computed tomography (PET-CT) identified enlarged lymph …
A 55-year-old, previously healthy woman received a diagnosis of diffuse large-B-cell lymphoma after the evaluation of an enlar …
Immunodeficiency in CHARGE syndrome.
Mehr S, Hsu P, Campbell D. Mehr S, et al. Am J Med Genet C Semin Med Genet. 2017 Dec;175(4):516-523. doi: 10.1002/ajmg.c.31594. Epub 2017 Nov 21. Am J Med Genet C Semin Med Genet. 2017. PMID: 29159871 Review.
Immunodeficiency can occur in CHARGE syndrome, with immunophenotypes including reduction in T-cell counts, combined T-B cell defects rarely requiring antibiotic prophylaxis or immunoglobulin replacement, and severe combined immunodeficiency, which is fatal wi …
Immunodeficiency can occur in CHARGE syndrome, with immunophenotypes including reduction in T-cell counts, combined T-B cel …
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL.
Griffin R, Wiedmeier-Nutor JE, Parikh SA, McCabe CE, O'Brien DR, Boddicker NJ, Kleinstern G, Rabe KG, Bruins L, Brown S, Bonolo de Campos C, Ding W, Leis JF, Hampel PJ, Call TG, Van Dyke DL, Kay NE, Cerhan JR, Yan H, Slager SL, Braggio E. Griffin R, et al. Blood Adv. 2023 Jul 11;7(13):3169-3179. doi: 10.1182/bloodadvances.2022009040. Blood Adv. 2023. PMID: 36877634 Free PMC article.
TP53 aberrations, including mutations and deletion of 17p13, are important adverse prognostic markers in chronic lymphocytic leukemia (CLL) but are less studied in high count monoclonal B-cell lymphocytosis (HCMBL), an asymptomatic pre-malignant stage of CLL. …
TP53 aberrations, including mutations and deletion of 17p13, are important adverse prognostic markers in chronic lymphocytic leukemia (CLL) …
371 results